Tirzepatide, a GLP-1 medication already on the market to treat diabetes, is now FDA approved to help those suffering from ...

You can do better than sleeping pills or counting sheep. From free apps and wearable trackers to smart mattresses and climate ...

Turkey: A recent study published in The Laryngoscope revealed a significant relationship between laryngopharyngeal reflux ...

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

As many as 17% of men and 34% of women in the United States suffer from sleep apnea, and the numbers are increasing. KYW ...

Background: A 60-year-old male with obesity (body-mass index 43 kg/m 2) presented with recurrent symptomatic atrial fibrillation (AF), which he had had since age 41 years. The AF was refractory to ...

on apnea-hypopnea index and body weight for adults with obesity and obstructive sleep apnea (OSA); and a prespecified analysis of the SELECT trial examining the effects of semaglutide (Wegovy ...

Gov. Jared Polis and the Colorado state legislature have the opportunity this year to pass a law to help our sickest and most ...

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

the association of daytime hypercapnia and obesity, obstructive airflow limitation, restrictive lung impairment, and severity of sleep apnea; and the response to continuous positive airway ...

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.